Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the safety and the prognosis after achieving reduced alcohol intake in patients with alcohol dependence who received treatment for the reduction of alcohol ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Otsuka Pharmaceutical Co., Ltd.
NCT07388693 · Alcohol Dependence
NCT06770556 · Alcohol Use Disorder, Alcohol Dependence, and more
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT06265506 · Alcohol Use Disorder, Alcohol Drinking, and more
NCT04014413 · Crohn Disease, Ulcerative Colitis, and more
Otsuka Pharmaceutical Co., Ltd.
Osaka
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions